NANO trademark on essential oils for oncology medicine granted to California Nanobles Corporation

David Uhalley and Mike Robinson, Nanobles Corporate Team

"Nanotechnology used to make medicines with essential oils is the future of our operation." -David Uhalley

“Nanotechnology used to make drugs with essential oils is the future of our operation.” -David Uhalley

Mike Robinson High Times Top 100 2021

Mike Robinson, the CEO of Corporations, is a cannabinoid medicine researcher who was just named one of the 100 most influential people in cannabis for 2021 by High Times magazine.

A Class 5 Oncology Medicine TM was granted to California-based nanotechnology company “Nanobles” led by Mike Robinson of the Global Cannabinoid Research Center

We can change the world using what Mother Earth has given us and a bit of technology based on quantum physics, nanotechnology is the present and the future.

—Mike Robinson, CEO, Nanobles, Inc.

SANTA BARBARA, CALIFORNIA, USA, May 3, 2022 / — With the rapid increase in cancers around the world, more treatment plan options with potentially devastating side effects are being created. But David Uhalley, partner and COO of the California Bay Area Nanobles Corporation, said the health and wellness company had reached a branding deal after negotiations with major pharmaceutical company NANO. “We have achieved Class 5 position for essential oils, including those from the cannabis plant,” he said.

Class 5 relates to pharmaceutical drugs. The nanotechnology company owns several trademarks escaping the creation of many other items for the nutraceutical and healthcare industries. Yet he has not aggressively advanced them to date, like this recent round of negotiations and the public news of their intent.

“As far as we know, essential oils have been used medicinally for tens of thousands of years – probably much longer,” said Mike Robinson, CEO of Nanobles. “We’ve found ways to blend essential oils and other soluble plant constituents to create topical layers of protection for oncology patients; it’s been in the works for years now; it’s ready for development. ”

Originally founded in 2019 by Uhalley alone, Robinson was his blogger and researcher. Mike Robinson, the founder of the Global Cannabinoid Research Center and the often-controversial figure for his daring online presence, was recently named to the High Times Top 100 Most Influential People in Cannabis for 2021, which features in the current edition of the newsstand.

“Oncology patients already face enough worries,” Uhalley said, giving no information about their creation. “As a cancer survivor, Mike has a passion for finding ways to block some of the treatments and needs to develop them, but it’s solid; the evidence is there to move forward. Stopping the harm means the skin isn’t hurt or not so badly – it also means the hair is more likely to stay in place or it can grow back much faster – I know that’s been her goal for three years.”

In 2020, founder David Uhalley reformed the company with Robinson as a 50% partner as CEO to develop the company’s intellectual property. Mike Robinson is also in charge of Research and Development. “We’re small but adequate; striking when the iron is hot has always been our thinking as we’re here for the long haul. I’ve never been one to join the cannabis industry itself as I just computer and robotics background and I haven’t been able to identify very well with different work cultures; I like the idea of ​​creating a prescriptible drug much better.”

His partner, however, has a different approach. “Preserving the cannabinoid of the plant is the name of the game for me,” he said, “I want to avoid going synthetic. transmit messages engraved in calculation.” Robinson was historically the director of communications for the American Academy of Cannabinoid Medicine. Yet even before that, he was a purveyor of compassionate oils who roamed the countryside, distributing them to those in need. He is known to have overcome several cancers by doing this.

Childhood cancer remains the leading cause of death by disease among children in the United States. Every day, 47 children are diagnosed with cancer and the average age of diagnosis is 8 years old. Cancer affects all ethnic, gender and socioeconomic groups, and more than 40,000 children undergo cancer treatment each year. “We hope to make a difference for these children, the ones we see used for advertisements. I know it helps to raise donations, but it makes me sad. Our trademark includes hair and skin growth for a right, but that’s Mike’s department.”

“According to the Lung Cancer Foundation, 1 in 16 people will be diagnosed with it in their lifetime,” Robinson said. “That means about 250,000 people in 2022 in the United States alone. All of them will face the potential of a treatment known to cause burns; if we can mitigate that, shouldn’t we? These treatments save lives, so if we can make them more manageable by using plant materials, why not? My theory is that plant materials can help people survive treatments that can also be deadly, like cancers. Yet this risk is often unavoidable, so supporting treatment is the only way to successfully help patients.

This team has been silent on the forefront of nanotechnology for the past two years, with minimal action on its website. “We had to fly under the radar as Mike created formulations that he could stabilize when everyone was on hiatus due to a global viral outbreak. Nothing was easy, and these creations are often highly sought after,” said said Uhalley. “There is no point in acquiring brands that you are not going to use, if you don’t use them other entities can sue you and try to take them away from you in this highly competitive market.”

Robinson is featured as a keynote speaker under his title at the Global Cannabinoid Research Center this year at the 2nd Global Summit and Expo on Nanotechnology and Nanomaterials (GSENN2022) to be held in Copenhagen, Denmark, from 13 to June 15, 2022.

mike robinson
+1 805-617-9539
[email protected]